OpenAlex
PricingAboutJobs
Log inGet started
Work

Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease

HTML

Year: 2017
Type: article
Source: Neuropharmacology
DOI: 10.1016/j.neuropharm.2017.06.026
Authors: Natalia Mast, Aicha Saadane, Ana Valencia-Olvera, James Constans, Erin Maxfield, Hiroyuki Arakawa, Young Li, Gary Landreth, Irina A. Pikuleva
Institutions: Case Western Reserve University, Indiana University School of Medicine
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: CYP46A1, cholesterol 24-hydroxylase, efavirenz, Alzheimer's disease, 5xFAD mice, amyloid-beta, brain cholesterol homeostasis, microglial activation, amyloid precursor protein, memory impairment, anti-inflammatory response, pharmacologic targets
SDG: Good health and well-being

Open Access status: green

Funders: U.S. Public Health Service, National Institute on Aging, National Eye Institute, National Institute of General Medical Sciences
Awards: Cholesterol Metabolizing P450s; structure and function, Actions of Nuclear Receptors on TREM2+ myeloid cells and microglia in AD brain, G7035501565, CWRU NEI Vision Center Core Grant
OpenAlex ID: W2700577086
FWCI: 3.736
Cites: 115
Cited by: 115
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security